SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
42 hedge funds and large institutions have $157M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $176M → $157M (-$19.2M)
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.61M | |
| 2 | +$677K | |
| 3 | +$329K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$250K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$242K |
Top Sellers
| 1 | -$832K | |
| 2 | -$427K | |
| 3 | -$193K | |
| 4 |
Goldman Sachs
New York
|
-$189K |
| 5 |
SIM
Spark Investment Management
New York
|
-$160K |